These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 4281339

  • 21. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A, Costa E.
    Biochem Pharmacol; 1975 Sep 01; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract] [Full Text] [Related]

  • 22. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK, Green AR.
    Neuropharmacology; 1980 Apr 01; 19(4):325-35. PubMed ID: 7383278
    [No Abstract] [Full Text] [Related]

  • 23. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
    Archer T, Fowler CJ, Fredriksson A, Lewander T, Magnusson O, Mohringe B, Söderberg U.
    Br J Pharmacol; 1985 Jul 01; 85(3):581-90. PubMed ID: 2411326
    [Abstract] [Full Text] [Related]

  • 24. 5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats.
    Abdel-Fattah AF, Matsumoto K, el-Hady KA, Watanabe H.
    Pharmacol Biochem Behav; 1995 Oct 01; 52(2):379-84. PubMed ID: 8577805
    [Abstract] [Full Text] [Related]

  • 25. Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor.
    Grahame-Smith DG, Green AR.
    Br J Pharmacol; 1974 Mar 01; 50(3):442P-443P. PubMed ID: 4853875
    [No Abstract] [Full Text] [Related]

  • 26. Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
    Abdel-Fattah AF, Matsumoto K, Murakami Y, El-Hady KA, Mohamed MF, Watanabe H.
    Jpn J Pharmacol; 1996 Sep 01; 72(1):39-47. PubMed ID: 8902598
    [Abstract] [Full Text] [Related]

  • 27. Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites.
    Pei Q, Lewis L, Sprakes ME, Jones EJ, Grahame-Smith DG, Zetterström TS.
    Neuropharmacology; 2000 Jan 28; 39(3):463-70. PubMed ID: 10698012
    [Abstract] [Full Text] [Related]

  • 28. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR, Mitchell BD, Tordoff AF, Youdim MB.
    Br J Pharmacol; 1977 Jul 28; 60(3):343-9. PubMed ID: 890205
    [No Abstract] [Full Text] [Related]

  • 29. Effects of repeated lithium administration on the subcellular distribution of 5-hydroxytryptamine in rat brain.
    Atterwill CK, Tordoff AF.
    Br J Pharmacol; 1982 Jul 28; 76(3):413-21. PubMed ID: 7104517
    [Abstract] [Full Text] [Related]

  • 30. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA, Lippmann W.
    J Pharm Pharmacol; 1977 Mar 28; 29(3):135-8. PubMed ID: 15075
    [Abstract] [Full Text] [Related]

  • 31. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G, Fernando JC, Marsden CA.
    Br J Pharmacol; 1978 Aug 28; 63(4):627-34. PubMed ID: 80243
    [Abstract] [Full Text] [Related]

  • 32. Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels.
    Moorman JM, Jackson A, Grahame-Smith DG, Leslie RA.
    Neuroscience; 1995 Oct 28; 68(4):1089-96. PubMed ID: 8544984
    [Abstract] [Full Text] [Related]

  • 33. Theanine-induced reduction of brain serotonin concentration in rats.
    Yokogoshi H, Mochizuki M, Saitoh K.
    Biosci Biotechnol Biochem; 1998 Apr 28; 62(4):816-7. PubMed ID: 9614715
    [Abstract] [Full Text] [Related]

  • 34. Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses.
    Green AR.
    Br J Pharmacol; 1978 Mar 28; 62(3):325-31. PubMed ID: 638311
    [Abstract] [Full Text] [Related]

  • 35. Effect of serotonin depletion induced by p-chloroamphetamine on changes in rats' activity levels-produced by lithium.
    Cappeliez P, White N, Duhamel JR.
    Neuropsychobiology; 1982 Mar 28; 8(3):129-34. PubMed ID: 6281681
    [Abstract] [Full Text] [Related]

  • 36. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ, Green AR, Boullin DJ, Grahame-Smith DG.
    Psychopharmacology (Berl); 1976 Sep 29; 49(3):287-300. PubMed ID: 12527
    [Abstract] [Full Text] [Related]

  • 37. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.
    Hollister AS, Breese GR, Kuhn CM, Cooper BR, Schanberg SM.
    J Pharmacol Exp Ther; 1976 Jul 29; 198(1):12-22. PubMed ID: 132524
    [Abstract] [Full Text] [Related]

  • 38. Effect of indolealkylamine manipulations on locomotor activity in rats.
    Jacobs BL, Eubanks EE, Wise WD.
    Neuropharmacology; 1974 Jul 29; 13(7):575-83. PubMed ID: 4280024
    [No Abstract] [Full Text] [Related]

  • 39. Molecular background and physiological consequences of altered peripheral serotonin homeostasis in adult rats perinatally treated with tranylcypromine.
    Blazevic S, Erjavec I, Brizic M, Vukicevic S, Hranilovic D.
    J Physiol Pharmacol; 2015 Aug 29; 66(4):529-37. PubMed ID: 26348077
    [Abstract] [Full Text] [Related]

  • 40. Does in vivo voltammetry in the hippocampus measure 5-HT release?
    Kennett GA, Joseph MH.
    Brain Res; 1982 Mar 25; 236(2):305-16. PubMed ID: 6461387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.